Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
117 Results Found
AHA Urges Administration to Grant Exceptions for Tariffs for Medications and Medical Supplies
The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the provision of safe, effective care in America's hospitals, clinics, and other settings.
AHA Response to OMB Deregulation RFI
AHA responds to the Office of Management and Budget Deregulation Request for Information.
AHA Comments on FTC Anticompetitive Deregulations RFI
The AHA provides an overview of the key statutes and regulations that have impeded competition in the health care market and offer a series of recommendations to remedy these obstacles.
AHA Comments on DOJ Anticompetitive Deregulations RFI
The AHA provides an overview of the key statutes and regulations that have impeded competition in the health care market and offer a series of recommendations to remedy these obstacles.
AHA Senate Letter Supporting Improving Seniors’ Timely Access to Care Act
AHA expresses support for Senate legislation, the Improving Seniors’ Timely Access to Care Act.
AHA House Letter Supporting Improving Seniors’ Timely Access to Care Act
AHA expresses support House legislation, the Improving Seniors’ Timely Access to Care Act.
AHA Responds to Commerce Department Investigation of Critical Minerals
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on processed critical minerals and derivative products.
AHA Response to FEMA RFI on Disaster Responses, Public Assistance Program
AHA's comment on our members’ experiences with the Federal Emergency Management Agency’s (FEMA) disaster responses, in particular the FEMA Public Assistance (PA) program
AHA Urges HHS to Reject the Effort by Several Large Drug Companies to Undermine the 340B Drug Pricing Program
AHA urges Secretary U.S. Department of Health and Human Services to reject the effort by several large drug companies to undermine the 340B Drug Pricing Program by imposing a “rebate model,”
AHA Supports House Save Healthcare Workers Act (H.R. 3178)
AHA expresses support for the House Save Healthcare Workers Act (H.R. 3178).